BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kafi-abad SA, Rezvan H, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007. Transfus Med 2009;19:189-94. [PMID: 19708860 DOI: 10.1111/j.1365-3148.2009.00935.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kabir K, Hoseini H, Miri M, Amrollahi F, Bahraini E, Afrogh P, Kalantar E. Prevalence of chronic viral hepatitis infections in Karaj, Iran. Pan Afr Med J 2017;28:186. [PMID: 29599884 DOI: 10.11604/pamj.2017.28.186.10269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Farshadpour F, Taherkhani R, Tajbakhsh S, Gholizadeh Tangestani M, Hajiani G, Sharifi N, Taherkhani S, Nejadbolkheyr A. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study. PLoS One. 2016;11:e0157615. [PMID: 27309959 DOI: 10.1371/journal.pone.0157615] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
3 Azadbakht M, Ardakani MT, Delirakbariazar M, Kasraian L, Khaledi A, Foruozandeh H, Salah A, Maleki F, Eshraghi M. Seroprevalence and Trend of HBV, HCV, and HIV Infections among Blood Donors of Fars Province, Iran (2006-2018). Ethiop J Health Sci 2020;30:397-408. [PMID: 32874083 DOI: 10.4314/ejhs.v30i3.11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Rad F, Sajjadi SM, Azizi A, Maghsudlu M. Confidential unit exclusion (CUE): Double edged sword for blood transfusion center: A ten-year study on volunteer blood donors in Kohgiluyeh and Boyer Ahmad province, Iran. Transfus Clin Biol 2019;26:253-6. [PMID: 31174915 DOI: 10.1016/j.tracli.2019.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Vasmehjani AA, Yaghubi S, Erfani Y, Hajikhezri Z, Farahmand M, Shayestehpour M, Adeli OA, Beiranvand M. Trend in Prevalence of Hepatitis B Virus Infection Among Blood Donor Individuals: An Eleven-year of Experience in Lorestan, Iran. Int J Prev Med 2020;11:178. [PMID: 33456734 DOI: 10.4103/ijpvm.IJPVM_260_18] [Reference Citation Analysis]
6 Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon 2016;16:e35664. [PMID: 27226804 DOI: 10.5812/hepatmon.35664] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
7 Pourkarim MR, Vergote V, Amini-Bavil-Olyaee S, Sharifi Z, Sijmons S, Lemey P, Maes P, Alavian SM, Van Ranst M. Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1. J Med Virol. 2014;86:745-757. [PMID: 24532489 DOI: 10.1002/jmv.23864] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
8 Ehsani AH, Ghodsi SZ, Nourmohammad-Pour P, Aghazadeh N, Damavandi MR. Pigmented purpura dermatosis and viral hepatitis: a case-control study. Australas J Dermatol 2013;54:225-7. [PMID: 23190427 DOI: 10.1111/ajd.12003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Emadi B, Ghahraman Rezaieh M, Sedighi M. Seroprevalence and trends of transfusion transmissible infections among retrospective blood donors in Western Azerbaijan Regional Blood Transfusion Center, Iran: A ten-years evaluation. Transfus Apher Sci 2021;60:103132. [PMID: 33846093 DOI: 10.1016/j.transci.2021.103132] [Reference Citation Analysis]
10 Amini-Kafiabad S, Pourfatollah AA. Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006-2015. Transfus Med 2021. [PMID: 34820928 DOI: 10.1111/tme.12833] [Reference Citation Analysis]
11 Abolhassani M, Nejad-Moghaddam A, Modaresi MH. Monoclonal antibodies against 24 kDa surface antigen of hepatitis B viruses. Monoclon Antib Immunodiagn Immunother 2013;32:132-5. [PMID: 23607349 DOI: 10.1089/mab.2012.0103] [Reference Citation Analysis]
12 Lindenberg Ade S, Motta-Castro AR, Puga MA, Ortiz Tanaka TS, Torres MS, Fernandes-Fitts SM, Cunha RV. Decrease in hepatitis B prevalence among blood donors in Central-West Brazil. J Venom Anim Toxins Incl Trop Dis 2013;19:7. [PMID: 23849137 DOI: 10.1186/1678-9199-19-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect. 2010;118:818-824. [PMID: 20172840 DOI: 10.1289/ehp.0901388] [Cited by in Crossref: 559] [Cited by in F6Publishing: 439] [Article Influence: 46.6] [Reference Citation Analysis]
14 Ramezani H, Bozorgi SH, Nooranipour M, Sadri M, Molaverdikhani S, Alavian SM. Successful exclusion of blood-borne viral disease in blood donors. Eur J Intern Med 2011;22:e71-4. [PMID: 22075316 DOI: 10.1016/j.ejim.2011.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
15 Abedi F, Madani H, Asadi A, Nejatizadeh A. Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B virus in Iran. Arch Virol 2011;156:629-35. [PMID: 21229276 DOI: 10.1007/s00705-010-0902-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]